Skip to main content

Table 2 Evaluation of the prognostic significance of SR-BI staining intensity

From: The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence

Variable P-value Risk ratio 95 % Confidence interval
Cancer vs. non-cancer <0.0001 2.128 1.693–2.675
GS ≥ 7 vs. GS ≤ 6 <0.0001 2.907 1.673–5.050
pT3/pT4 vs. pT2 0.371 1.269 0.739–2.182
Met. pos. vs. met. neg. 0.207 1.351 0.837–2.182